Enhanced anti-breast cancer efficacy of co-delivery liposomes of docetaxel and curcumin.
Enhanced anti-breast cancer efficacy of co-delivery liposomes of docetaxel and curcumin.
复制标题
多西他赛和姜黄素的共递送脂质体的抗胸腺癌疗效增强。
DOI:
10.3389/fphar.2022.969611
复制
发表时间:
2022
影响因子:
5.6
通讯作者:
Meng, Xiangyun
中科院分区:
文献类型:
--
作者:
Ye, Xi;Chen, Xin;He, Ruixi;Meng, Wangyang;Chen, Weidong;Wang, Fengling;Meng, Xiangyun
The successful treatment of breast cancer is hampered by toxicity to normal cells, impaired drug accumulation at the tumor site, and multidrug resistance. We designed a novel multifunctional liposome, CUR-DTX-L, to co-deliver curcumin (CUR) and the chemotherapeutic drug docetaxel (DTX) for the treatment of breast cancer in order to address multidrug resistance (MDR) and the low efficacy of chemotherapy. The mean particle size, polydispersity index, zeta potential, and encapsulation efficiency of CUR-DTX-L were 208.53 ± 6.82 nm, 0.055 ± 0.001, −23.1 ± 2.1 mV, and 98.32 ± 2.37%, respectively. An in vitro release study and CCK-8 assays showed that CUR-DTX-L has better sustained release effects and antitumor efficacy than free drugs, the antitumor efficacy was verified by MCF-7 tumor-bearing mice, the CUR-DTX-L showed better antitumor efficacy than other groups, and the in vivo pharmacokinetic study indicated that the plasma concentration–time curve, mean residence time, and biological half-life time of CUR-DTX-L were significantly increased compared with free drugs, suggesting that it is a promising drug delivery system for the synergistic treatment of breast cancer.
登录
查看更多内容
影响因子:
5.8
作者:
Abouzeid, Abraham H.;Patel, Niravkumar R.;Torchilin, Vladimir P.
通讯作者:
Torchilin, Vladimir P.
影响因子:
2
作者:
Berrios-Caro, Ernesto;Gifford, Danna R.;Galla, Tobias
通讯作者:
Galla, Tobias
影响因子:
5.8
作者:
Cheng, Ce;Wu, Zhihua;Liu, Wei
通讯作者:
Liu, Wei
影响因子:
4.5
作者:
Cheng Ji;Wen Na;Zhu Jia-Bi
通讯作者:
Zhu Jia-Bi
影响因子:
3.4
作者:
Du, S.;Deng, Y.
通讯作者:
Deng, Y.